United States: The Multi-District Litigation Statute Needs Rewriting

Last Updated: December 19 2016
Article by James Beck

It's hard to believe that, with over half of all cases pending in the federal courts now docketed in multi-district litigations ("MDLs"), the statutory basis for all this litigation is but one section of the United States Code:

  1. When civil actions involving one or more common questions of fact are pending in different districts, such actions may be transferred to any district for coordinated or consolidated pretrial proceedings. Such transfers shall be made by the judicial panel on multidistrict litigation authorized by this section upon its determination that transfers for such proceedings will be for the convenience of parties and witnesses and will promote the just and efficient conduct of such actions. Each action so transferred shall be remanded by the panel at or before the conclusion of such pretrial proceedings to the district from which it was transferred unless it shall have been previously terminated: Provided, however, That the panel may separate any claim, cross-claim, counter-claim, or third-party claim and remand any of such claims before the remainder of the action is remanded.
  2. Such coordinated or consolidated pretrial proceedings shall be conducted by a judge or judges to whom such actions are assigned by the judicial panel on multidistrict litigation. For this purpose, upon request of the panel, a circuit judge or a district judge may be designated and assigned temporarily for service in the transferee district . . . The judge or judges to whom such actions are assigned, the members of the judicial panel on multidistrict litigation, and other circuit and district judges designated when needed by the panel may exercise the powers of a district judge in any district for the purpose of conducting pretrial depositions in such coordinated or consolidated pretrial proceedings.
  3. Proceedings for the transfer of an action under this section may be initiated by −
    1. the judicial panel on multidistrict litigation upon its own initiative, or
    2. motion filed with the panel by a party in any action in which transfer for coordinated or consolidated pretrial proceedings under this section may be appropriate. A copy of such motion shall be filed in the district court in which the moving party's action is pending.

[Procedures for the JPML deliberations on creating MDLs, notice, and filing of transfer orders]

  1. [Composition of JPML]
  2. [Restrictions on appealability of JPML orders]
  3. The panel may prescribe rules for the conduct of its business not inconsistent with Acts of Congress and the Federal Rules of Civil Procedure.
  4. [Peculiar to antitrust]
  5. [Peculiar to antitrust]

28 U.S.C.A. §1407.

That's it. There are as many subsections of the MDL statute (2) peculiar to antitrust as there are governing the substance of what MDLs are intended to accomplish.

Given the percentage of the federal docket now represented by MDLs – and in particular MDLs involving prescription medical products – it's high time for Congress to revisit (repeal and replace?) the MDL statute. How are MDLs assigned under current law? The statute offers no guidance. How are these monsters to be organized? Ditto. To what extent, if at all, can MDL judges depart from the federal rules in pursuit of "just and efficient" procedures. Ditto. We could go on....

Moreover, recent grotesque miscarriages of MDL procedures, mostly but not exclusively involving so-called "bellwether" trials, cry out for a legislative fix. Indeed, given that the current statute specifies that "such actions may be transferred to any district for coordinated or consolidated pretrial proceedings," the source of an MDL judge's authority to try anything is quite questionable under the current language.

MDLs as currently situated suffer from two fundamental flaws that distort what Congress was attempting to accomplish back in 1968 when §1407 was created and in 1976, when it was last amended. First, expansion of First Amendment protection has permitted an explosion of lawyer advertising. Such mass solicitation – much of it financed by third parties with no interest beyond stirring up litigation, has led to massive numbers of cases being filed with little or no pre-suit investigation. These cases, which could not survive individually, clog everything up in MDLs, intimidate both judges and defendants by their sheer numbers, and persist for years. Perpetuation of meritless claims by MDLs has been a complaint at every conference we've attended over the past few years. MDL judges are also well aware of the problem:

[T]he Court had to waste judicial resources deciding motions in cases that should have been dismissed by plaintiff's counsel earlier − cases that probably should never have been brought in the first place. Enough is enough.

In re Mentor Corp. Obtape Transobturator Sling Products Liability Litigation, 2016 WL 4705827, at *1 (M.D. Ga. Sept. 7, 2016) (resorting to Rule 11 sanctions).

These hide-the-ball practices have become so notorious that, as we discussed recently, the Seventh Circuit found an abuse of discretion to award a plaintiffs' MDL counsel a quantum meruit recovery after being fired – because counsel might not have done any work that deserved a fee. Dobbs v. DePuy Orthopedics, Inc., ___ F.3d ___, 2016 WL 7015648, at *4 (7th Cir. Dec. 1, 2016) (quantum meruit "applies when the attorney did 'much work,' which still requires analyzing the factors used to determine a reasonable fee. . . . We do not intend to insinuate that some lesser award is required") (citations omitted). Allowing MDLs to become warehouses for meritless litigation is directly contrary to the "just and efficient" conduct of litigation that was the original raison d'être for the statute. Now, it's more like the Field of Schemes − "build it and they will sue."

Second, settlement has become the yardstick by which MDL judges "succeed" in their administration of MDLs. As a result, all too many judges resort to procedural methods that seek to bludgeon defendants into offering big dollars to resolve what are mostly worthless claims. Defendants are denied use of Rule 8 and other case-specific motions; denied case-specific discovery; and confronted with novel theories of liability and evidentiary rulings from out of left field. Plaintiffs get to pick only their best cases for bellwether trials, and they routinely dismiss without penalty the defense picks often after defendants have invested a great deal of time and effort in them. The bellwethers trials themselves are hardly representative (even if they started out that way) since they evolve into World War III − ten-week show trials with far more resources invested by both sides than the damages in that case could conceivably justify were the action to have been remanded. Increasingly, these show trials feature multi-plaintiff consolidation so that the inference of "where there's smoke, there's fire" becomes overwhelming. In this respect, the original goal of the MDL process, with respect to settlement, has been lost. That goal was to determine the true value of claims, so that parties can resolve them, not to use sheer numbers to hide worthless claims, or to distort case values with billion dollar outlier verdicts that are representative of nothing, and accomplish little – except to provide fodder for still more advertising.

We frankly have no idea whether or not multi-district litigation is anywhere on the new administrations' radar screen. But we doubt a Trump Administration would be opposed, and the new attorney general might be persuadable. Thus, our clients should definitely make an effort to put MDL reform on the congressional agenda. We've had a lot of experience with MDLs, and we've talked recently with others in the same situation. Thus, here are some amendments to the MDL statute that we'd like to see.

First and foremost, the original purpose of MDLs as a device for "coordinated or consolidated pretrial proceedings" should be vindicated. Since the current "pretrial" language is effectively being ignored, perhaps Congress needs to repeat the language it previously used in CAFA, "solely for pretrial proceedings," at the end of the phrase in §1407(a), cf. 28 U.S.C.A. §1332(d)(9). Congress could be even more explicit, withholding authority from MDL courts to conduct binding jury or bench trials without the continuing consent of all parties. Trial consolidations of multiple plaintiffs alleging only harm from the same product should be expressly prohibited, both in the MDL and after remand. The sheer numbers of clients that plaintiffs' counsel can solicit should never be allowed to trump defendants Due Process rights.

Congress should state that the operative paradigm of a "successful" MDL is not a huge settlement accompanied by a huge payout (such as the "Vioxx model" discussed at ACI). That model leads to too many abuses. The operative instructions should stop being "don't you dare send any cases back," as we have heard expressed. Instead, the expectation should be that only the "good" cases not dismissed by dispositive pre-trial motion will either be settled or remanded – and that "bad" cases, the 95% that no plaintiff-side lawyer would bring individually, will be dismissed.

To further enforce the pretrial nature of MDLs, a time limit (perhaps two years) for how long any case should remain in the transferee court should be imposed. Eliminating trials (bellwether or otherwise) means that the prejudicial consolidations and gamesmanship with case selection become moot, and the potential for punitive evidentiary rulings is much reduced. The number of appeals from MDLs would also be reduced, and appellate courts would face less pressure to affirm or else "waste years of effort."

Eliminating trials would also reduce the problem of MDLs venued in places having nothing to do with the litigation, explainable only as some form of "spread the litigation wealth." Transparent criteria should be developed so that the siting and assignment of MDLs no longer resembles political patronage, which has no place in the federal judiciary. While Congress need not itself decide such siting and assignment criteria, it should set deadlines for the Federal Judicial Center, or some similar expert body, to do so.

To further focus MDLs on pretrial matters, Congress could also direct that the JPML develop clearer rules on: (1) discovery so that "proportional" plaintiff-specific discovery also occurs in MDLs, and courts on remand are presented with trial-ready cases not needing large amounts of case-specific discovery; (2) remanding cases when "proportional" discovery and pretrial motion practice has been completed; (3) management and staging of case remands; and (4) when MDLs should be closed to new cases and/or terminated.

But won't changes that emphasize remand create huge backlogs in the federal courts? Not if Congress puts an end to current MDL practices that allow tens of thousands of unvetted cases to persist for years. These sheer numbers mislead both the courts and the parties about the true scope of the litigation, as many of the so-called "cases" cannot even make it past the minimal hurdles of "Did you use the product?" or "Did you sustain the injury claimed?"

That brings us to our second basket of proposed amendments. First, MDL judges should be required to follow rules of civil procedure that are intended to cull out weak cases, in particular Rule 8 as applied in TwIqbal. To reduce the workload that eliminating the current evasions of the Federal Rules would entail, defendants should be allowed to file Rule 8/12 motions in the transferor court and have those resolved prior to transfer. A second workload reducer would be to amend §1407 to permit temporary re-transfers (including of directly filed cases). In both instances, transferor courts more familiar with the applicable state's law could help decide case-specific motions.

A Rule 8/12 procedure would weed out cases where basic information within a plaintiff's control is lacking, such as domicile, product identification, prescriber identification, date and type of injury, theory of defect, reliance, and learned intermediary causation (in warning cases). Since this procedure would primarily target factually unsupported claims, perhaps the statute should require a short, verified plaintiff questionnaire limited to this specific information to be filed within 60 days of the transfer of a case to the MDL – with the questionnaire (rather than wildly differing complaints) considered the operative Rule 8 pleading for Rule 12 purposes. To deal with more factually complex issues, inappropriate (but not novel) legal theories, and the rights of defendants to file case-specific summary judgment motions should likewise be preserved, perhaps subject to a similar temporary re-transfer provision.

But won't that make more work for the MDL judge? Probably, and we have two responses. First, the temporary re-transfer provision allowing MDL judges to enlist the help of transferor judges should significantly reduce the amount of extra work. Second, if an MDL judge doesn't want the work, s/he shouldn't volunteer to become a transferee judge in the first place, since judges cannot be assigned MDLs without their consent. It might not be a bad idea to require at least five years on the bench before a judge can seek an MDL assignment.

Numerous other amendments could also lessen the ability of plaintiffs to park large numbers of meritless cases without adverse consequence. First, any amendment to §1407 should include require Lone Pine orders at some relatively early stage of the proceedings – say, six months after transfer – unless waived by all defendants. Second, no consolidated multi-plaintiff complaints should be allowed in MDLs (if anywhere). Mandatory severance of unrelated plaintiffs should be required, with filing fees paid for each case individually. MDLs make more work for court clerks, too, and filing fees should provide some recompense. Third, rather than have defendants pay to track down medical records, it should be the plaintiff's obligation to turn these over, as it is ordinarily, with cost-shifting for omissions for plaintiffs failing to do this. Proportionality principles in discovery should require plaintiffs, as well as defendants, to produce all discovery relevant to their claims and defenses, and to foot the bill under the usual producer pays model. Fourth, at least in states that allow it, defendants should have the right to informally interview willing prescribing/treating physicians (subject to notice).

To combat plaintiffs' use of MDLs as incubators of novel legal theories not previously recognized under relevant state law, we further propose that §1407 – if not the entire federal judiciary – be subject to a "Preservation of State Law" provision along the lines of what we previously proposed here.

Finally, we recognize the toothpaste in the tube problem − that, to the extent that amendments to §1407, along the lines suggested above, make MDLs less attractive to plaintiffs (and the funders of their advertisements that generate so many baseless claims), they will turn to their usual forum-shopping bag of tricks to avoid federal court altogether. One aspect of combatting such a development would be for the United States Supreme Court to overturn the California Bristol-Myers Squibb personal jurisdiction decision on due process grounds. That alone would eliminate a lot of forum-shopping.

A second, legislative, approach would involve one more amendments to §1407 (or perhaps to 28 U.S.C. §1332), that after an MDL has been created, federal jurisdiction and the corresponding right to remove should require only CAFA-style minimal diversity in state court cases that share common questions with the MDL. Indeed, preventing plaintiffs from Balkanizing federal and state proceedings in MDL cases would preclude a great deal of gamesmanship, much of it involving plaintiff-side infighting, and by gathering all cases in one forum, provide a better opportunity for settling those cases that deserve to be settled.

We're not proposing to change substantive law (at least not here). We're not proposing to change Daubert or defenses like preemption. Every one of the proposals we make is procedural – designed to tame the MDL monster and return it to the pre-trial scope that Congress intended when it enacted §1407. Statutory MDL reform along these lines should be a top priority for our colleagues and clients in the upcoming Congress.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
James Beck
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.